Future Pak maintains a pristine FDA and GDUFA compliance record, having never received a warning letter across nearly fifty years of operation.
Its privately held structure allows flexible, scaled contract manufacturing and packaging across blister packs, bottles, stick packs, pouching, and cartoning for pharmaceutical and nutraceutical customers.
Future Pak operates across retail, specialty, and institutional pharmaceutical and nutraceutical markets from its Wixom, Michigan facility.
The company expanded its footprint through the 2025 acquisition of Theratechnologies, a Montreal-based specialty biopharmaceutical company, broadening its reach into commercial-stage biopharmaceutical products.
Future Pak quotes custom pharmaceutical packaging engagements on a per-project basis, inviting customers to request tailored quotes for their packaging and manufacturing needs.
The privately held operator scales production runs from small to large volumes, pricing each contract according to the specific format and volume required.